Publications
- Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- IL-1 inhibition in the treatment of autoinflammatory diseases in children2020 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | Second Faculty of Medicine
- Gastrointestinal Involvement in Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity2023 | Second Faculty of Medicine
- The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective2023 | Second Faculty of Medicine
- Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy2023 | Second Faculty of Medicine
Loading network view...